Drug Sponsors and Their External Service Partners Say Adjusting Relationship Models Offers a Path to Greater Performance and Efficiency, According to Tufts Center for the Study of Drug Development
October 08, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Oct 8, 2013) - While drug sponsor use of strategic relationships with contract service providers has increased dramatically during the past five years, improvements in...
Healthier Croissants and Danishes, Better WOW From Smarter Drinks and Soy-Dairy Cheese Tech on Offer From University of Guelph to Global Agri-Businesses
October 07, 2013 09:00 ET
|
Ontario Food Cluster
COLOGNE, GERMANY--(Marketwired - Oct 7, 2013) - ANUGA 2013 -- Whether it's building a better Danish, expanding the types of ingredients that can be used in the next generation of smart beverages or...
Avaya Earns Third Edison Award for Innovation in Collaboration and Communications
September 19, 2013 09:01 ET
|
Avaya Inc.
SANTA CLARA, CA--(Marketwired - Sep 19, 2013) -
2013 Edison Award received for patent enabling continuous communications during an emergency or network outage now...
Clinical Study Failures Vary Widely by Phase of Study and Therapeutic Class, According to the Tufts Center for the Study of Drug Development
September 10, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Sep 10, 2013) - While lack of commercial viability is the leading cause of Phase I failures for new drug candidates, efficacy issues dominate as the reason for Phase II...
Concurrent Technologies Corporation Recognized as a Top 100 Research and Development Federal Contractor by Centurion Research Solutions
August 14, 2013 10:17 ET
|
Concurrent Technology Corp.
JOHNSTOWN, Pa., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Concurrent Technologies Corporation (CTC) has been recognized as one of Centurion Research Solutions' Fiscal Year 2012 (FY12) Top 100 Research and...
Drug Industry Leaders See Collaboration as Key to Greater Productivity, According to Tufts Center for the Study of Drug Development
August 13, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Aug 13, 2013) - Responding to a widely shared need to improve the probability of R&D success, leaders from the research-based drug industry, recently convened by...
STATS ChipPAC and Nanyang Technological University Collaborate on New Innovative Packaging Technologies
August 12, 2013 17:00 ET
|
STATS ChipPAC
SINGAPORE -- 13 AUGUST 2013, UNITED STATES--(Marketwired - Aug 12, 2013) - STATS ChipPAC Ltd. ("STATS ChipPAC" or the "Company") (SGX-ST: STATSChP) (SGX: S24), a leading provider of advanced...
Binswanger Named Exclusive Agent for Medical Research Facility in Chazy, New York
July 30, 2013 09:47 ET
|
Binswanger
NEW HAVEN, CT--(Marketwired - Jul 30, 2013) - Binswanger has been named exclusive agent by Northstar 41, LLC to represent them with the sale and/or lease of a state-of-the-art medical research...
Number of Annual New Drug Approvals to Treat Neglected Diseases Has Nearly Doubled Between the Early-2000s and 2009-12, According to the Tufts Center for the Study of Drug Development
July 11, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Jul 11, 2013) - The annual number of new drug approvals worldwide to treat neglected diseases has nearly doubled in recent years, with HIV/AIDS and malaria drugs...
Clinical Success Rates for New Cancer Drugs Doubled From the Mid-1990s to Early-2000s, According to the Tufts Center for the Study of Drug Development
May 07, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - May 7, 2013) - Clinical success rates for new cancer drugs doubled between the mid-1990s to the early 2000s, while the number of new cancer drugs entering clinical...